ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| Rubius Therapeutics, Inc. Delisted | — | United States of America | — | 279 |
| Affimed N.V. | 0HL9 | Netherlands | — | 278 |
| AngioLab, Inc. | 251280 | South Korea | — | 278 |
| POINT Biopharma Global Inc Delisted | PNT | United States of America | — | 278 |
| Virpax Pharmaceuticals, Inc. Delisted | — | United States of America | — | 278 |
| 에스엘테라퓨틱스 Delisted | 258540 | South Korea | — | 276 |
| Intellicell Biosciences, Inc. Delisted | — | United States of America | — | 276 |
| Samaritan Pharmaceuticals Inc Delisted | SPHC | United States of America | — | 274 |
| MIRAVANT MEDICAL TECHNOLOGIES Delisted | — | United States of America | — | 273 |
| ObsEva SA Delisted | — | United States of America | — | 273 |
| Renascience Inc. | 4889 | Japan | — | 273 |
| Receptos, Inc. Delisted | — | United States of America | — | 272 |
| Awakn Life Sciences Corp. (1169082 BC Ltd.) | AWKN | Canada | — | 271 |
| Enumeral Biomedical Holdings, Inc. Delisted | — | United States of America | — | 271 |
| OWC Pharmaceutical Research Corp. Delisted | — | United States of America | — | 271 |
| Tsubota Laboratory Incorporated | 4890 | Japan | — | 271 |
| Altamira Therapeutics Ltd Delisted | CYTO | Bermuda | — | 270 |
| Nirvana Life Sciences Inc | NIRV | Canada | — | 270 |
| LYSOGENE Delisted | LYS | France | — | 269 |
| Immunotech Biopharm Ltd | 6978 | Hong Kong | — | 266 |
| Marvel Biosciences Corp. | MRVL | Canada | — | 266 |
| OMNI BIO PHARMACEUTICAL, INC. Delisted | — | United States of America | — | 264 |
| Celator Pharmaceuticals Inc Delisted | CPXX | United States of America | — | 263 |
| curacle co., ltd. | 365270 | South Korea | — | 263 |
| STEM CELL INNOVATIONS, INC. Delisted | — | United States of America | — | 262 |
| Trubion Pharmaceuticals, Inc Delisted | — | United States of America | — | 262 |
| AP Biosciences Inc | 6945 | Taiwan | — | 261 |
| DexTech Medical AB | DEX | Sweden | — | 259 |
| Jiangsu Recbio Technology Co., Ltd. | 2179 | China | — | 258 |
| Inhibrx Inc Delisted | INBX_old | United States of America | — | 257 |
| Vaxil Bio Ltd. | VXL | Canada | — | 257 |
| 13260917 Canada Inc. Delisted | MSCL | Canada | — | 256 |
| Icagen, Inc. Delisted | — | United States of America | — | 256 |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6549 | Taiwan | — | 256 |
| Applied Molecular Transport Inc Delisted | AMTI | United States of America | — | 254 |
| AveXis Inc Delisted | AVXS | United States of America | — | 254 |
| HLB SCIENCE Inc. Delisted | 343090 | South Korea | — | 254 |
| Ra Pharmaceuticals Inc Delisted | RARX | United States of America | — | 253 |
| Icosavax Inc Delisted | ICVX | United States of America | — | 252 |
| Kiromic Biopharma Inc | KRBP | United States of America | — | 252 |
| AprilBio Co.,Ltd. | 397030 | South Korea | — | 251 |
| Longboard Pharmaceuticals Inc Delisted | LBPH | United States of America | — | 251 |
| TaiRx, Inc. | 6580 | Taiwan | — | 250 |
| Vitae Pharmaceuticals, Inc Delisted | — | United States of America | — | 250 |
| HEXIMA LIMITED. | HXL | Australia | — | 249 |
| SYMBOLLON CORP Delisted | — | United States of America | — | 249 |
| Alcobra Ltd Delisted | ADHD | United States of America | — | 248 |
| PsyBio Therapeutics Corp. Delisted | PSYBF | Canada | — | 248 |
| Myrexis, Inc. Delisted | — | United States of America | — | 247 |
| Translate Bio Inc Delisted | TBIO_old | United States of America | — | 247 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.